Venous Thromboembolism

Venous thromboembolism (VTE) is the formation of thrombus in the venous system, presenting most often as deep vein thrombosis (DVT) of the legs and, when a clot embolises to the lungs, as pulmonary embolism (PE). It is a common, potentially fatal condition that links surgical, medical, and immobilised patients and is a major target of prophylaxis.

Definition

Venous thromboembolism is a disease spectrum in which thrombus forms within deep veins (deep vein thrombosis) and may detach and travel to the pulmonary arteries (pulmonary embolism); the two manifestations share risk factors and pathophysiology and are managed as a single thromboembolic entity.

Scope

This entry covers the pathophysiology of venous thrombosis, the relationship between deep vein thrombosis and pulmonary embolism, the determinants of thrombosis captured by Virchow's triad, and the broad principles of prevention and anticoagulant treatment. It is a reference topic within vascular surgery fundamentals and does not provide individualized clinical advice or dosing.

Core questions

• How do the elements of Virchow's triad combine to produce venous thrombosis?
• Why are deep vein thrombosis and pulmonary embolism considered one disease?
• What distinguishes provoked from unprovoked VTE and why does it matter?
• How is the risk of recurrent thrombosis balanced against bleeding from anticoagulation?

Key concepts

• Deep vein thrombosis
• Pulmonary embolism
• Virchow's triad (stasis, endothelial injury, hypercoagulability)
• Provoked versus unprovoked VTE
• Thromboprophylaxis
• Anticoagulation
• Post-thrombotic syndrome

Key theories

Virchow's triad

Venous thrombosis is conventionally understood to arise from the interaction of three categories of factor - venous stasis, endothelial injury, and a hypercoagulable state - a framework attributed to Rudolf Virchow that remains the standard way of organising VTE risk factors.

Mechanisms

Venous thrombi typically form where blood is stagnant, such as the valve pockets of deep leg veins, when the balance is tipped by reduced flow (stasis), damage to the endothelium, or an increased tendency to clot (hypercoagulability) - the three arms of Virchow's triad. A thrombus may extend proximally, partly resolve, or detach and embolise through the right heart into the pulmonary arteries, where it obstructs flow and strains the right ventricle, producing pulmonary embolism. Anticoagulation does not dissolve existing clot directly but prevents propagation and recurrence while the body's fibrinolytic system acts; the duration of treatment depends on whether the event was provoked by a transient risk factor (agnelli-2010, kearon-2012, ortel-2020).

Clinical relevance

VTE is a frequent and sometimes fatal complication of surgery, immobility, malignancy, and inherited thrombophilia, and its prevention is a routine part of perioperative and hospital care. The entry explains how the disease is conceptualised and risk-stratified for educational reference; choices about prophylaxis, anticoagulant selection, and treatment duration for any individual rest on current guidelines and clinical judgement, not on this overview, and no dosing is given here (kearon-2012, ortel-2020).

Epidemiology

VTE is among the most common vascular conditions, with incidence rising with age and strongly increased by surgery, hospitalisation, immobility, cancer, pregnancy, oestrogen exposure, and inherited thrombophilias. Pulmonary embolism is an important cause of preventable in-hospital death, which is why thromboprophylaxis is emphasised across surgical and medical patients (agnelli-2010, kearon-2012).

History

The conceptual foundation of VTE dates to Rudolf Virchow's nineteenth-century analysis of the factors predisposing to venous thrombosis and embolism, summarised in the triad that bears his name. Modern management developed through the twentieth and twenty-first centuries with heparins, vitamin K antagonists, and more recently direct oral anticoagulants, alongside structured guidelines for prophylaxis and treatment (kearon-2012, ortel-2020).

Debates

Duration of anticoagulation after unprovoked VTE

Whether and for how long to continue anticoagulation after an unprovoked event balances the ongoing risk of recurrence against the cumulative risk of bleeding, and the optimal strategy for individual risk profiles remains actively discussed in guidelines.

Key figures

• Rudolf Virchow

Seminal works

• kearon-2012
• ortel-2020
• agnelli-2010

Frequently asked questions

What is the relationship between DVT and pulmonary embolism?

They are two manifestations of the same disease: a deep vein thrombosis can dislodge and travel through the heart to the lungs, becoming a pulmonary embolism, so the two are managed together as venous thromboembolism.

What is Virchow's triad?

It is the classic framework describing the three contributors to venous thrombosis - slowed blood flow (stasis), injury to the vessel lining (endothelial injury), and an increased tendency of the blood to clot (hypercoagulability).